{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:29:42Z","timestamp":1785914982624,"version":"3.56.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T00:00:00Z","timestamp":1337644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001657","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T23:24:54Z","timestamp":1337729094000},"page":"e1657","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":95,"title":["Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis"],"prefix":"10.1371","volume":"6","author":[{"given":"Vasundhra","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Kulshrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Deep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Schonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Salotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.","volume":"2","author":"PJ Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"ref2","article-title":"Expert Committee on Control of the leishmaniases.","year":"2010"},{"key":"ref3","year":"2007"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4269\/ajtmh.2005.73.1005","article-title":"A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.","volume":"73","author":"TK Jha","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980\u20132004.","volume":"5","author":"PL Olliaro","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref6","first-page":"345","article-title":"Visceral leishmaniasis - current therapeutic modalities.","volume":"123","author":"S Sundar","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00001432-200212000-00007","article-title":"Advances in the treatment of leishmaniasis.","volume":"15","author":"S Sundar","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1517\/14656566.6.16.2821","article-title":"Treatment of visceral leishmaniasis.","volume":"6","author":"S Sundar","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis.","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref10","article-title":"Expert Committee on Regional Strategic Framework for Elimination of Kala-azar from the South-East Asia Region (2005\u20132015)","year":"2005"},{"key":"ref11","first-page":"105","article-title":"Kala-azar status in SEA Region.","volume":"45","author":"A Joshi","year":"2008","journal-title":"J Vector Borne Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.trstmh.2005.09.015","article-title":"Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.","volume":"100","author":"S Sundar","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2133.2011.10402.x","article-title":"Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis.","volume":"165","author":"V Ramesh","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref14","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala-azar in India.","volume":"83","author":"S Sundar","year":"2005","journal-title":"Bull World Health Organ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4269\/ajtmh.2009.80.580","article-title":"Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient.","volume":"80","author":"BD Pandey","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/AAC.01694-08","article-title":"Low plasma membrane expression of the miltefosine transport complex renders <italic>Leishmania braziliensis<\/italic> refractory to the drug.","volume":"53","author":"MP Sanchez-Canete","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by <italic>Leishmania (Viannia) guyanensis<\/italic> in Manaus, Brazil.","volume":"84","author":"A Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for visceral leishmaniasis in India.","volume":"356","author":"S Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"ref19","article-title":"Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in India.","author":"PK Sinha","year":"2011","journal-title":"J Trop Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"<italic>Leishmania donovani<\/italic> resistance to miltefosine involves a defective inward translocation of the drug.","volume":"47","author":"FJ Perez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both <italic>L. donovani<\/italic> miltefosine transporter and the new protein LdRos3 in <italic>Leishmania<\/italic> parasites.","volume":"281","author":"FJ Perez-Victoria","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4269\/ajtmh.1983.32.475","article-title":"Quantitation of amastigotes of <italic>Leishmania donovani<\/italic> in smears of splenic aspirates from patients with visceral leishmaniasis.","volume":"32","author":"JD Chulay","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4269\/ajtmh.2007.76.896","article-title":"Cutaneous leishmaniasis caused by <italic>Leishmania tropica<\/italic> in Bikaner, India: parasite identification and characterization using molecular and immunologic tools.","volume":"76","author":"R Kumar","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1128\/AAC.00812-10","article-title":"Antimony-resistant clinical isolates of <italic>Leishmania donovani<\/italic> are susceptible to paromomycin and sitamaquine.","volume":"55","author":"A Kulshrestha","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","article-title":"Primer3.","author":"SS Rozen","year":"1998"},{"key":"ref26","article-title":"Chromas Chromas Pro Software Version 1.32."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"In vitro susceptibility of field isolates of <italic>Leishmania donovani<\/italic> to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.","volume":"53","author":"D Kumar","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of <italic>Leishmania donovani<\/italic> promastigotes resistant to hexadecylphosphocholine (miltefosine).","volume":"22","author":"K Seifert","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.6.8.1381","article-title":"Miltefosine to treat leishmaniasis.","volume":"6","author":"J Berman","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/425359","article-title":"Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection.","volume":"39","author":"H Sindermann","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00365540701466215","article-title":"Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients.","volume":"40","author":"J Troya","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/505079","article-title":"Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.","volume":"194","author":"R Singh","year":"2006","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1101\/gr.123430.111","article-title":"Whole genome sequencing of multiple <italic>Leishmania donovani<\/italic> clinical isolates provides insights into population structure and mechanisms of drug resistance.","volume":"21","author":"T Downing","year":"2011","journal-title":"Genome Res"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:53:07Z","timestamp":1588981987000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001657"}},"subtitle":[],"editor":[{"given":"Elodie","family":"Ghedin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,22]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001657","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,22]]}}}